Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aphria

High Tide becomes the first major publicly traded cannabis retailer to announce it has been approved to trade on Nasdaq. High Tide shares expected to begin trading on Nasdaq on June 2 nd, 2021 High Tide has received approval from Nasdaq to list its common shares for trading under the symbol "HITI" CALGARY, AB, May 28, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV: HITI) (OTCQB: HITID) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce that the Company's application to list its common shares ("Shares") on the Nasdaq Capital Market ("Nasdaq") has been approved.

Nasdaq Approves High Tide's Application to List

The Company's patented technology expected to be key to commercial success in cannabinoid biosynthesis NASDAQ | TSX: ACB EDMONTON, AB, May 27, 2021 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the launch of a dedicated Science & Innovation business group, with the aim of commercializing patented and patent pending technology that the Company believes will be key in the development of cannabinoid biosynthesis and plant genetics.   Aurora's connection to the biosynthetic production of cannabinoids originated with early work carried out by the Company's former Chief Science Officer on the discovery of key genes within the cannabinoid biosynthesis pathway.

New Science & Innovation Business Unit to Advance Aurora's Leadership in Biosynthesis and Plant Genetics

Canopy Growth

Tilray Brands

GrowGeneration Corp

SNDL Inc.

Today, cannabis stocks are soaring as legalization legislation is expected to materialize this week, alongside other bullish catalysts. The post Cannabis Stocks: The Big News Sending TLRY, CGC, ACB, GRWG, SNDL Stocks Higher appeared first on InvestorPlace.

Cannabis Stocks: The Big News Sending TLRY, CGC, ACB, GRWG, SNDL Stocks Higher

Are These Canadian Cannabis Stocks A Good Investment? The post Which Of These Marijuana Stocks Are The Best To Invest In? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Which Of These Marijuana Stocks Are The Best To Invest In?

NASDAQ | TSX: ACB EDMONTON, AB, May 24, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced that it has completed the transfer of its stock exchange listing to The Nasdaq Global Select Market ("Nasdaq") from the New York Stock Exchange ("NYSE") after the market close today. The Company's common stock will begin trading as a Nasdaq-listed security at market open on May 25, 2021 and will continue to be listed under the ticker symbol "ACB.

Aurora Cannabis to Begin Trading on the The Nasdaq Global Select Market on May 25, 2021 at Market Open

Investors see "more" chances of marijuana legalization soon.

Why Aurora Cannabis Stock Popped Friday

OrganiGram Holdings Inc.

New data from Statistics Canada revealed that Canadian cannabis sales in March improved 65% year-over-year reaching CA$298.1 million ($246.7 million), reports New Cannabis Ventures. According to the outlet, this was the “slowest year-over-year growth” since recreational sales in the country began in late 2018.

Canadian Cannabis Sales In March Improve 65% YoY Reaching $246.7M

Canadian cannabis company Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB) is seeking to raise $300 million by selling its commons shares through the at-the-market offering. The move came on the heels of confirming that its subsidiary Aurora Germany GmbH extended its collaboration with Grow Group PLC.

Aurora Cannabis To Raise $300M, Files Prospectus Supplement For ATM Offering Program Ahead Of Transfer To NASDAQ

Grow Group PLC said it has extended a strategic relationship with Canadian firm Aurora Cannabis Inc (NYSE:ACB) by signing a two-year market access services agreement for the UK following an initial agreement in 2019. “Everything we do is with the patient in mind.

Grow Group renews medical cannabis market access agreement with Aurora Cannabis

Aurora Cannabis Inc. filed for a potential sale of $300 million in fresh shares Thursday, and mentioned the possibility of a U.S. acquisition. The Canadian cannabis company announced that it planned a $300 million at-the-market share offering while releasing quarterly earnings last week, and filed a prospectus with the Securities and Exchange Commission for the sale on Thursday.

Aurora Cannabis files for stock sale, mentions U.S. acquisition possibility

NYSE | TSX: ACB EDMONTON, AB, May 20, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, has filed a prospectus supplement establishing a new at-the-market equity program (the "ATM Program") that allows the Company to issue and sell up to U.S.$300 million of common shares in the capital of the Company (the "Common Shares") from treasury to the public, from time to time, at the Company's discretion. Any Common Share sales under the ATM Program will be made through "at-the-market distributions" as defined in National Instrument 44-102 and sold through the NASDAQ Global Select Market (the "NASDAQ") or other marketplace in the United States at the prevailing market price at the time of sale.

Aurora Announces Filing of Prospectus Supplement for At-The-Market Offering Program

HEXO Corp

When the federal Cannabis Act came into effect in October 2018 and Canada became the second country in the world, after Uruguay, to legalize adult-use cannabis, needless to say, the market exploded. Today the biggest names in the Canadian cannabis space include Aurora Cannabis (NYSE: ACB), Canopy Growth (NASDAQ: CGC), Hexo (NYSE: HEXO), Organigram Holdings (NASDAQ: OGI), and Tilray (NASDAQ: TLRY).

Analyst: Aurora, Canopy, Tilray And Other Canadian Cannabis Co. Performances By Province

Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB) confirmed Thursday its subsidiary Aurora Germany GmbH has extended its collaboration with a United Kingdom-focused biopharmaceutical company Grow Group PLC. The two companies signed a two-year market access services agreement for the U.K. Previously, the Canadian cannabis giant was one of the first companies to partner with Grow Group in August 2019.

Aurora Cannabis Focuses On U.K. Medical Cannabis Market, Expands Its Collaboration With Grow Group On Heels Of NASDAQ Transfer

NYSE | TSX: ACB EDMONTON, AB, May 20, 2021 /PRNewswire/ - Aurora Germany GmbH, a subsidiary of Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, and Grow Group PLC ("Grow"), a biopharmaceutical company focused on improving access to cannabis-based medicines in the United Kingdom ("UK"), today announced the extension of their long-standing strategic relationship by signing a two-year market access services agreement for the UK. Aurora was one of the first companies to enter into a strategic relationship with Grow in August 2019 and since then, both companies have become leaders in the rapidly growing medical cannabis market in the UK.

Aurora Cannabis and Grow Group PLC Renew Market Access Services Agreement for Medical Cannabis in the United Kingdom

Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.

Do Options Traders Know Something About Aurora Cannabis (ACB) Stock We Don't?

Innovative Industrial Properties

Scotts Miracle-Gro

Stick to companies with a track record of success where it counts.

How to Buy Cannabis Stocks During a Bear Market

Cronos Group

The cannabis industry is faced with two main objectives: Finding the right product to competitively grow and then finding the right place to actually set up operations. Sale-leaseback options are a financing tool cannabis companies are increasingly using in their pursuit of non-traditional financing.

Sale/Lease Buyback Model - Why It's the Hottest Funding Method for Cannabis Properties Now and Why It May Soon Not Be So Hot…

Sundial delivered on what Aurora has been promising.

How Sundial Growers Trounced Aurora Cannabis in Their Latest Earnings Updates

EDMONTON, AB, May 14, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that the Company will be participating at the BMO Capital Markets 16th Annual Farm to Market Virtual Conference. Chief Executive Officer, Miguel Martin, and Chief Financial Officer, Glen Ibbott, will be conducting virtual one-on-one meetings with investors throughout the day on Wednesday, May 19 and Thursday, May 20, 2021.

Aurora to Participate in BMO Capital Markets Farm to Market Virtual Conference

Aurora Cannabis slid the day after the Canadian grower posted a wider-than-expected loss. Wall Street analysts weren't impressed with results.

Aurora Cannabis Stock Is Sliding After Disappointing Results. What Wall Street Is Saying.

Aurora Cannabis (TSE: ACB) tanked 9% in the stock market on Friday morning as the company reported another big loss for its fiscal third quarter. The company also announced share-sale plans, cost-cutting, and executive changes late on Thursday.

Here's why Aurora Cannabis lost 9% on Friday morning

The company slid an announcement concerning a new share offering at the bottom of its quarterly financial report.

Why Aurora Cannabis Stock Sank Friday

Canadian cannabis company Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) posted its third-quarter of fiscal 2021 financial results on Thursday with revenue of CA$58.4 million ($48.1 million), down by 19.5% year-over-year, and 17% sequentially. The Edmonton, Alberta-based company also revealed a negative adjusted EBITDA of CA$24 million, which compares to a loss of CA$49.6 million in the same period of the prior year.

Should Aurora Exit Recreational Market? Analysts Dissect Cannabis Co. Earnings

Curaleaf Holdings, Inc.

Akerna Corp

Amplify Alternative Harvest ETF

Cambria Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal.

Are Any Canadian Marijuana Stocks Good Buys As Earnings Disappoint?

Applied DNA Sciences

Arena Pharmaceuticals

Cara Therapeutics

Corbus Pharmaceuticals Holdings

Flora Growth Corp

Village Farms International

cbdMD Inc

Zynerba Pharmaceuticals

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.

News for Aurora Cannabis Stock (ACB)